Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
71 hedge funds and large institutions have $8.66M invested in Ampio Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 74 → 71 (-3)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
45% less capital invested
Capital invested by funds: $15.8M → $8.66M (-$7.1M)
69% less call options, than puts
Call options by funds: $52K | Put options by funds: $166K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$208K |
| 2 |
Renaissance Technologies
New York
|
+$162K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$89.2K |
| 4 |
SG Americas Securities
New York
|
+$65.1K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$467K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$255K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$96K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$55K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$48.5K |
AMPE Hedge Fund Activity: Q3 2016 in Review
71 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2016, worth a combined $8.66M — down 45% from $15.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AMPE and 6 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 13 added.
The largest buyer was Vanguard Group, adding an estimated $208K. The largest seller was Knoll Capital Management, cutting an estimated $467K.
- 71 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2016, down from 74 in Q2 2016.
- Funds reported $8.66M of Ampio Pharmaceuticals Inc. stock for Q3 2016, down 45% quarter-over-quarter.
- 6 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2016 and 8 closed out, a net change of -2 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2016 was Vanguard Group, an estimated $208K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2016 was Knoll Capital Management, an estimated $467K sold.
Based on aggregated 13F filings for Q3 2016.